Upstream Bio, Stock Price on November 8, 2024
UPB Stock | 19.19 0.26 1.34% |
If you're considering investing in Upstream Stock, it is important to understand the factors that can impact its price. As of today, the current price of Upstream Bio, stands at 19.19, as last reported on the 28th of December, with the highest price reaching 20.17 and the lowest price hitting 18.80 during the day. Upstream Bio, appears to be somewhat reliable, given 3 months investment horizon. Upstream Bio, owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0653, which indicates the firm had a 0.0653% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Upstream Bio,, which you can use to evaluate the volatility of the company. Please review Upstream Bio,'s Coefficient Of Variation of 1532.23, risk adjusted performance of 0.0609, and Semi Deviation of 5.63 to confirm if our risk estimates are consistent with your expectations.
As of December 28, 2024, Total Stockholder Equity is expected to decline to about (129.3 M). In addition to that, Capital Stock is expected to decline to 2,400. Upstream Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Upstream |
Sharpe Ratio = 0.0653
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | UPB | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.92 actual daily | 61 61% of assets are less volatile |
Expected Return
0.45 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Upstream Bio, is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Upstream Bio, by adding it to a well-diversified portfolio.
Upstream Bio, Main Headline on 8th of November 2024
Upstream Bio Advances Clinical Trials, Strengthens Financial... by news.google.com
Upstream Bio Advances Clinical Trials, Strengthens Financials TipRanks
Upstream Bio, Valuation on November 8, 2024
It is possible to determine the worth of Upstream Bio, on a given historical date. On November 8, 2024 Upstream was worth 27.43 at the beginning of the trading date compared to the closed value of 26.18. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Upstream Bio, stock. Still, in general, we apply an absolute valuation method to find Upstream Bio,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Upstream Bio, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Upstream Bio,'s related companies.
Open | High | Low | Close | Volume | |
26.50 | 27.59 | 26.45 | 27.02 | 117,574 | |
11/08/2024 | 27.43 | 29.30 | 25.18 | 26.18 | 153,200 |
26.42 | 27.82 | 25.82 | 26.80 | 218,146 |
Backtest Upstream Bio, | | | Upstream Bio, History | | | Upstream Bio, Valuation | Previous | Next |
Upstream Bio, Trading Date Momentum on November 8, 2024
On November 11 2024 Upstream Bio, was traded for 26.80 at the closing time. Highest Upstream Bio,'s price during the trading hours was 27.82 and the lowest price during the day was 25.82 . The net volume was 218.1 K. The overall trading history on the 11th of November 2024 contributed to the next trading period price jump. The trading price change to the next next day price was 2.37% . The trading price change to current price is 1.57% . |
About Upstream Bio, Stock history
Upstream Bio, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Upstream is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Upstream Bio, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Upstream Bio, stock prices may prove useful in developing a viable investing in Upstream Bio,
Upstream Bio, Stock Technical Analysis
Upstream Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Upstream Bio, Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
Upstream Bio, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Upstream Bio, December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Upstream Bio, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Upstream Bio, shares will generate the highest return on investment. By undertsting and applying Upstream Bio, stock market strength indicators, traders can identify Upstream Bio, entry and exit signals to maximize returns
Upstream Bio, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Upstream Bio,'s price direction in advance. Along with the technical and fundamental analysis of Upstream Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Upstream to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0609 | |||
Jensen Alpha | 0.4272 | |||
Total Risk Alpha | 0.2491 | |||
Sortino Ratio | 0.0667 | |||
Treynor Ratio | 0.671 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Upstream Stock analysis
When running Upstream Bio,'s price analysis, check to measure Upstream Bio,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio, is operating at the current time. Most of Upstream Bio,'s value examination focuses on studying past and present price action to predict the probability of Upstream Bio,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio,'s price. Additionally, you may evaluate how the addition of Upstream Bio, to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Money Managers Screen money managers from public funds and ETFs managed around the world |